OFFICIAL PUBLICATION OF

by its subsidiary APPco

Melanoma treatment to be PBS-listed

Megan Haggan 29/06/2015

melanoma: dermatologist examines mole on woman's shoulder

MSD has welcomed the Federal Government’s announcement that patients with the most deadly form of skin cancer – advanced melanoma – will be able to access the company’s anti-PD1 immunotherapy (pembrolizumab) on the PBS. Keytruda is a prescription-only medicine suitable for adult patients with unresectable or metastatic melanoma. News that Keytruda will be listed on

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

Melanoma treatment to be PBS-listed

Previous Newly-identified enzyme key player in diabetes

Next MERS: thanks to international travel, Australia's not immune

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Newly-identified enzyme key player in diabetes

Next MERS: thanks to international travel, Australia's not immune

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.